| Title: |
211MO First-line efficacy of [177Lu]Lu-DOTA-TATE in patients with advanced grade 2 and grade 3, well-differentiated gastroenteropancreatic neuroendocrine tumors by tumor grade and primary origin: Subgroup analysis of the phase III NETTER-2 study |
| Authors: |
Singh, S.; Halperin, D.; Myrehaug, S.; Herrmann, K.; Pavel, M.E.; Kunz, P.L.; Chasen, B.; Capdevila, J.; Tafuto, S.; Oh, D-Y.; Yoo, C.; Falk, S.; Halfdanarson, T.R.; Folitar, I.; Zhang, Y.; de Herder, W.W.; Ferone, D. |
| Source: |
Annals of Oncology ; volume 35, page S92-S93 ; ISSN 0923-7534 |
| Publisher Information: |
Elsevier BV |
| Publication Year: |
2024 |
| Collection: |
ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1016/j.annonc.2024.05.219 |
| Availability: |
https://doi.org/10.1016/j.annonc.2024.05.219; https://api.elsevier.com/content/article/PII:S0923753424003582?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S0923753424003582?httpAccept=text/plain |
| Rights: |
https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: |
edsbas.925AB9F2 |
| Database: |
BASE |